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INTRODUCTION 
It is the purpose of this paper to determine if a 
re1e"tionship exists bet"ween the initial peripheral blood 
smear and bone marrow findings and the eventual prognosis 
of a pa tj.ent with chronic lymphocytic leukemia. In this 
paper prognosis refers to the length of survival of the 
patient. 
Since chronic lymphocytic leukemia is fairly common 
in older patients and is compatible with life for a rela-
tively long time, an effort will be made to determine if 
such a patient's survival can be predicted with any degree 
of accuracy_ 
The information for t.his study is derived from the 
heme"tology files of the Department of Internal )\·~edicine 
and the Tumor Survey at the University of Nebraska College 
of Hedicine. This series includes patients i!lho were known 
to have chronic lymphocytic leukemia and i'rho 'tlere follmv-
eO. durin€) their clinical course. Thj.s covers a time in-
terval from 1950 to 1963. 
Each patient was evaluated as to age at diagnosis, 
sex and race, date of diagnosis, associated dictgnoses, 
first symptom to consultation, consultation to diagnosis, 
diagnosis to first treatment and the type of treatment 
used. Data on the peripheral blood smea,r '\lIaS limited 
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to anctlysts of the hemoglobin, total white blood cell 
count, retlculocytes and pIa telets. The bone marrO'Vi 
was studied for its relative cellularity, gross evalu-
ation of plasma cells and percentage of cells in the 
lymphocytic series. 
DIAGNOSTIC INFOfm.IATION 
Of the total 64 cases, 42 were males and 22 were 
females. This is a ratio of approximately tirfD males to 
one female 0 Sixty-two of these cases were white and 
two were Negro. 
The mean age at the time of diagnosis i'laS 67.0 
yaars with the men having a meaD age of 68.0 years and 
the women having a mean age of 65.1 years. The oldest 
patient in this series was 87, yea,rs and the youngest 
was 38 years. Almost 40% of the patients were in the 
eighth decade (70-79). This is graphically l"epresented 
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Fig. 9. Age at Diagnosis of Chronic Lympho-
cytic Leukemia in 64 cases. 
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At the present tlme 1~4 of these patlents have died 
while 20 are still living. The patients that died sur-
yived an average of 3.20 years after the onset·of symptoms 
and 2.76 years after the diagnosis of chronic lympho-
cytic leukemia. "ras confirmed. Ten of these patients 
died of diseases that 'tiere probe~bly not directly related 
to the leukemia. That is, seven of them died of car-
ci::"lOma and three of them from a myocardial infe.rction. 
The lonGest survival in this group \u~,s nine years and 11 
months i'lhile the shortest \-las one 1vee::':. 
However, the 20 patients that are still living 
already have lived an average of 5.22 years after the 
onset of symptoms and 4.51 years after the confirmation 
of a diagnosis of chronic IJ~phocytic leukemia. The 
longest survivor has already had symptoms for 15 years 
'while the most recent case has had symptoms about 8 months. 
When the whole group of 64 patients is analyzed, a 
mean value of 3.85 years is arrived at as the length of 
survival or duration of the illness after the onset of 
sJ~ptoms. A mean value of 3.31 years is the correspond-
ing period of time after a positive diagnosis was made. 
Figur'e 2 represents a graphic illustratj.on of these findings. 
It is this mean value of 3.31 years that the various 
blood findings will be compared. HO"ileVer, since 20 of 
these patients are still living, it is obvious that the 
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mean value is only an absolute minimum fo!" the length 
of survival. A_s these patients continue to live this 
figure will become larger. 
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Fig. 20 Duration of illness ln 64 patlents ",li th 
chronic lymphocytic leukemia from the 
onset of clinical symptoms. 
In evaluatlng this series of patients as to their 
prognosis the laboratory studies at, or as close to 
the time of diagnosls as possible, were studied. In 
all cases, however, at least some laboratory data ""as 
recorded before treatment was started. Some of the 
specific blood and bone marro\v values were not avail-
able for each patient. As these particular values are 
encountered, this \,lil1 be noted.. Concluslons \vill be 
based only upon the available evidence. 
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PERIPHERAL BLOOD SIJIEAR 
A hemoglobin valv'3 Fas availe.ble on each of the 
64 patients. These values ranged from a low of 3.7 Gm. % 
to a high of 16.7 Gm. % 1'lith a rrean of 11.5 Gm. %. Fig-
ure 3 is included to try and show Borne relationship 
betltleen the initial hemoglobin value and the patient' B 
length of survival a.fter diagnosis. 
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Fig. 3. The Gm. % of hemoglobin in 64 patients with 
chronic lymphocytic leukemia as compared 
to the length of survival after diagnosis. 
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~ value for the white blood cell count was also 
obtained on all 64 patients. The lowest count at or 
near the time of diagnosis was 4,100 per cu. mm., and 
the highest count "vT8.S 576,000 per cu. mm. with a mean 
value of 82,200 per cu. mm. Figure 4 is used to show 
the relationship of the white blood cell count to the 
length of survival after diagnosis. 
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Fig. 4. White blood cell counts in 64 patients with 
chronic lymphocytic leukemia as compared to 
the years of survival after diagnosis 
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A d1fferentle,1 white cell count we,s available 
on 56 patients at or near the time of d1agrosis. A 
mean value for the percentage of cells in the lymphocytic 
series was 81%. The vast majority of the cells were 
mature lymphocytes or smudge cells. Only occasi.onally 
WG.s a prolyr;phocyte or lymphoblast present in the periph-
eral smear. 
The percentage of reticulocytes was recorded in 
38 patients at or near the time of diagnosis. The 
lowest value \vas 0.2% and the highest value vIas 6 .. 3% 
wi th a melin of 1.4%. The normal reticulocyte response 
.. ,.ras considered to be betvleen 0.5% and 1.5%. The percent-
age of ret1culocytes is compared to the patient's dura-
tion of chronic lymphocytic leukemia after diagnosiS 
by figure 5. 
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Fig. 5. Reticulocytes (%) in 38 patients with chronic 
lymphocytic leukemia as compared to the years 
of survival after diagnosis. 
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An indication of the number of platelets in all 
64 patients viaS available at or near the time of diag-
nosis. How"ever, in about one-half of the patients only 
a gross indication of the number present was recorded. 
That is, a note was made that the platelets were normal, 
increased or decreased. In the remainder of the patients 
an absolute value was given. Figure 6 shows the re1a-
tionship of the number of platelets to the years of 
survival after diagnosis. The normal platelet count 
:In the peripheral blood was assumed to be 150,000-
600,000 per cu. mm. 
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Fig. 6. Number of platelets per cu. mm. in 64 patients 
with chronic lymphocytic leukemia as compared 
to the years of survival after diagnosis. 
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BONE ~1ARr1.0W FINDINGS 
Because of the importance in diagnosis of chr.onic 
lymphocytic leukemia, the bone marrow findings at or 
near the time of die,gnosis were studied in 58 patients. 
In six of the patients enough marrO\,l fragments were 
not obtained to be of diagnostic value. 
The degree of cellularity in the initial bone marrow 
was recorded for 54 of the patients in thj.s series. The 
degree of cellularity was stated as being hypocellular, 
moderately cellular (normal), slightly hypercellular, 
moderately hypercellular or markedly hypercellular. 
Figure 7 shows the relationship of the degree of oell-
ula,ri ty to the years of survival after diagnosis. 
o I Z. J q. r , ? S 9 /4 ~I /.1. /3 /~ /s-
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Fig. 7. The ~egree of cellularity in 54 patients with 
chronic lymphocytic leukemia as compared to 
the years of survival after diagnosis. 
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The number of plasma cells in the initial bone mar-
row was also evaluated in an effort to correlate it with 
the length of survival after diagnosis. A plasma cell 
determination was available on only 30 of the patients 
in this series. The results were listed as being decreased, 
normal or increased in number. The normal number' of 
plasma cells in the bone marrow is considered to be 0.0-
2.0 per cu. mm. 13 However, the plasma cells were con-
sidered to be decreased if none were found on the bone 
marrow examine,tion. Figure 8 shov;'s the relationship of 
the number of plasme cells in the bone marrow and the 
years of survival after diagnosis. 
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Fig. 8" The plasma, cells in the bone me.rrow of 30 patients 
with chronic lymphocytic leukemia as compared 
to the years of survival after diagnosis. 
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The percentage of cells of the lyn:phocytic series 
in the bone marrow at or near the time of diagnosis was 
recorded for 58 patients in this series. fJlost of the 
cell s ,,,,ere mature lYlllphocytes \vi th a fevl prolymphocytes 
and an occasional lymphoblast. The 10\l>lest percentage of 
cells in the lymphocytic series was 10% :i.n one patient 
while four patients t me.rro1l1s \-lere 100;;s replaced. The 
calculated mean value was 66.2% for the entire series of 
patients. Figure 9 shows the relationship between the 
percentage of cells of the lymphocytic series and the 
length of survival after diagnosis. 
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Fig. 9. The percentage of cells of the lymphocytic series 
in the bone marrow of 58 patients with chronic 
lYlllphocytic leukemia as compared to the years of 
survival after diagnosis. 
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TREA T1<!ENT 
Because of the multiple forms of treatment used on 
most patients, it is difficult to show any correlation 
between the length of survival and treatment with any 
specific agent. A tabulated list of treatments shO'lrfs 
that some form of X-ray therapy was used in 34 patients, 
triethylenemelamine in 26 patients, chlorambucil (Leu-
keran) in seven patients, phosPhorus32 in four patients, 
nitrogen mustard in one patient, aminopterin in one patient, 
cortisone in one patient, prednisone in one patient, 
iodine131 in one patient, supporting therapy in six 
patients and no therapy in six patients. 
DISCUSSION 
In this study of 64 patients with chronic lympho-
cytic leukemia the mean age was determined to be 67.0 
years. The mean survival time after diagnosis was cal-
culated to be 3.31 years. According to the U.S. Bureau 
of the Census, the average person may expect to live 
13.1 yearslO after reaching the age of 67 years. There-
fore, it would appear that chronic lymphocytic leukemia 
had a marked effect upon the patientfs expected survival. 
However, in order to state that this was statistically 
signif'icant a control group of patients would be neces-
sary. 
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In a series of 137 patients studied by Shimkin9 
the mean age of onset was 54.3 years. This is consider-
ably lower than the mean age of 67.0 years in this series. 
His mean survival from the time of diagnosis to death was 
3.5 years. He found tha.t the initial leukocyte count 
failed to have any correlation with the length of survi-
val. 
8 The longest mean survival time was reported by Osgood 
in a series of 102 patients with chronic lymphocytic leu-
32 kemia who were treated with phosphorus • He determined 
that the mean survival time was about seven years. How-
ever, this vias only estimated by the "method of maximum 
lik IiI d" h' b 11 d t h~ t d b m' 11 e LOO w ~c. was app _e 0 ~s s u y y ~~vey • 
The latter author has shown that survival times in leu-
kemia follow logarithm-normal distributions. Therefore, 
if one plots the lEingth of time that a patient has had 
leukemia on log paper, he can estimate the length of 
his expected survival. This method of determining sur-
vival rates was not used in this study. Admittedly how-
ever, it would probably have given the final conclusions 
more validity. 
11 
In one of the largest series reported Tivey studied 
1,978 patients with chronic lymphocytic or granulocytic 
leukemia. He demonstrated that there was no difference 
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between the survival prospects of patients with lympho-
cytic and patients with granulocytic leukemia. He 
showed that half of the patients will die in about 
2.65 years after onset of the first clinical symptoms 
and that 10% will live seven years after the onset of 
the disease while 1% will survive 15 years. 
In another large series of 649 patients with 
chronic leukemia (both lymphocytic and. granulocytic) 
1 l.'eported by Feinleib the median duration of survival 
after diagnosis was 11.65 months. 
Lawrence4 in a study of 100 patients with chronic 
lymphocytic leukemia reported a mean survival of 4.5 
years. 
In analyzing the laboratory data of this study the 
hemoglobin values l'lill be considered fil:"st. According 
to Wasi12 , before the availability of radioisotope tech-
nics it was generally accepted that replacement of 
erythroblasts by leukemic cells was the mechanism by 
which anemia developed. However, since the bone marrOyl 
was rarely biopsied, this opinion was based almost entirely 
on the histopathology of the marrow at autopsy; patients 
early in the natural history of their disease were not 
studied. In Wasi t s12 study all the patients with a nor-
mal hemoglobin level had a normal amount of erythroblastic 
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tissue and the degree of anemia i<vas roughly correlated 
\ill th the decrease in erythroblastic tissue. 
There is also a massive replacement of the myeloid 
tissue as \'lell as erythroblastic tissue. These elements 
are replaced by the lymphatic tissue. It therefore seems 
reasonable that the degree of anemia would be 9roportional 
to the decrease in erythroblastic tissue and hence, to the 
increB,se in lymphatic tissue. It might be expected that 
a patient's prognosis could then be estimated on the basis 
of the hemoglobin value. This is assuming of course, that 
the replacement of the bone marrow with lymphatic tissue 
carries a poor prognosis. 
The results of this study seem to give support for 
the above reasoning. On examining figure 3 it is observed 
that most of the values are clustered in the upper left 
triangle of the graph. Of the 32 value,s under 12 Gm.% 
22, or 69%, d:led before reaching the mean survival of 3.31 
years. Of the 32 values above 12 Gm. % 18, or 56%, lived 
longer than 3.31 years. 
The peripheral lymphocyte count may also be a measure 
of the amount of lymphatic tissue in the marrow and 
hence, an indication of the progression and duration 
of the disease in a specific patlent. 12 The expected 
result might be that a high lymphocyte count indicates 
a poor prognosis. 
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This was again shown to have some correlation. 
~~en figure 4 is studied, it is observed that most of 
the values are clustered in the upper right triangle. 
Of the 29 values greater than 50,000 white blood cells 
per cu. mm. 16, or 55%, died before surviving 3.31 years. 
Te~or 29%, of the values less than 50,000 died before 
surviving 3.31 years. 
The percentage of reticulocytes was also included 
in this study because of its direct correlation with 
erythropoietic activity_ An increase in the number of 
reticulocytes in the peripheral blood is indicative of 
erythropoietic hyperactivity while a decreased number 
or a normal or only slightly increased number in the 
presence of anemia is indicative of hypoactivity or 
inadequate regenerative response. 7 Therefore, if the 
marrow is replaced by lymphatic tissue, this may be 
reflected in the peripheral blood by a decrease in reti-
culocytes. It is the purpose of this study to see if 
this would indicate a poor prognosis. 
The values in figure 5 are clustered in the lower 
left triangle. There are 14 ve.lues the.t fall outside 
of the nO~illal range of 0.5-1.5%. Only five, or 36%, 
lived longer than the mean survival time. Ten of the 
24 values, or 42%, lived longer than 3.31 years. 
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Thrombocytopenia is not prominent throughout the 
greater part of the course in most cases of chronic 
lyw.phocytic leukemia, although it commonly develops 
terminally, usually as part of an aplastic syndrome of 
marrow failure with accompanying failure of red cell 
2 production. If marrmv- failure is indicative of a poor 
prognosis, then it is possible that a reduction in the 
number of platelets in the peripheral blood may also be 
associated with a poor prognosis. 
The majority of values in figure 6 are clustered 
in the lower left tri.angle. Sixteen values fall outside 
of the normal range of 150,000-600,000 per cu. mm. Only 
two, or 12%, of these patients lived longer than 3.31 
years. Twenty-one, or 44%, of the values within the 
normal range lived longer than the mean survival period. 
Because of the method used in reporting platelet deter-
minations (decreased, normal, increased, etc.), it was 
not possible to arrive at an actual mean platelet value. 
Since the degree of cellularity in the bone marrow 
is usually proportional to the degree of lymphatic 
infiltration in chronic lymphocytic leukemia, this may 
sive some indication of the patient's prognosis. It 
was also not possible to arrive at a mean cellularity 
value because of the method used in reporting the 
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findings. None of the patients were found to have 
hypocellular marrows. Of the seven patients with nor-
mal marrow cell~larity four, or 52%, survived longer 
than the mean 3.31 years. A better correlation was 
observed in the group of 19 patients ..,Ii th markedly 
hypercellular bone marrows at the time of diagnosis. 
Seventeen, or 90%, of these patients died before reaching 
the mean survival interval of 3.31 years. 
The serum proteins in chronic lymphocytic leul:emia 
may show more striking variations from normal than are 
seen in other forms of leukemia. This is to be expected 
in view of the close relationship of lymphocytes to 
plasma cells and other cellular components of the lymphoid 
and reticulo-endothelial system, with their probable func-
tions in elaborating antibodies' and globulins. Nevertheless, 
no consistent abnormalities of electrophorectic protein 
patterns occur, and the majority of patients with 
clinically mild chronic lymphocytic leulremia shmi' no 
differences from normal. At later stegee of the disease 
a marked increase :tn gamma globu,lins mAy be found, or 
" the''''e may be a conspicuous hypogammaglobulinemia.-
3 According to Klein and Block plasma cells produce 
serum antibodies. Although there is still no uniformity 
of opinion concerning the function of plasma cells, they 
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believe there can be little doubt that plasma cell pro-
liferation is usually associated with elevated plasma 
globulin leyels. If this is true, then there may be 
some correlation between the number of plasma cells 
in the bone marrow at the time of diagnosis and the 
eventual prognosis of the patient. 
Only 30 patients in this series had their bone 
marrow plasma cell findings recorded. Of this number 
only six were reported as being decreased. Five of 
these, or 83%, died before the mean survival period of 
3.31 years. Only four patients had bone marrows that 
showed an increase in plasma cells. Three of these, 
or 75%, also died before the mean survival period of 
3.31 years. The remaining 20 patients had a normal 
number of plasma cells in their marr01rTS. 
Efforts to correlate the patient's prognosis with 
the percentage of cells in the lymphocytic series in 
the bone marrow was also attempted. It seems reasonable 
to assume that the greater the percentage of cells in 
the lymphocytic series, the greater the progression of 
the disease and hence, the poorer the prognosis. 
Twenty-eigbt patients had more than 70% of their 
bone marrow replaced with cells in the lymphocytic series. 
Sixteen, or 57%, of these died before reaching the mean 
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survi,val period.. Eighteen, or 60%, of the patients with 
less than 70% of their marro'l:/ replaced also di,ed before 
reaching the mean survival period. 
It is interesting to compare these blood findings 
6 
with a report by Marlow of a patient who lived 29 years 
with chronic lymphocytic leukemia. His initial hemo-
globin was 75% (about 10 Gm .. %), white blood cell count 
was 48,800 and the i,nitial differential showed 86% 
lymphocytes. 
SUMMARY 
A series of 64 patients i'ii th chronic lymphocytic 
leukemia was studied to determine if their prognosis 
could be predicted by the peripheral blood smear and 
bone marrow findings at the time of diagnosis. 
The sex ratio was about 2:1 with the males predom-
inating. 
The mean age at the time of diagnosis was 67.0 
years with a range of from 38 years to 87 years. 
Presently, 20 of the patients are living and 44 
have died. The deceased patients lived an average of 
2.76 years after diagnosis. The living patients have 
survived for a mean period of 4.51 years since being 
diagnosed. All patients :tn this series, as 8. group, 
have a mean survival value of 3.31 years. It is this 
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figure that is used to compare with the various blood 
findings. 
Of the 32 patients with hemoglobins below 12 Gm.% 
69% survived less than 3.31 years. Fifty-six per cent 
of the patients 'I'lhose hemoglobin was above 12 Gm.% 
died in the same time interval. 
Of the 29 patients who had white blood cell counts 
higher than 50,000 per cu. mm. 55% lived less than the 
mean survival time. Those with counts below 50,000 
per cu. mm. had 29% that did not live 3.31 years. 
The mean value for the percentage of cells of the 
lymphocytic series in the differential was 81%. 
The normal reticulocyte response was considered 
to be 0.5-105%. Only 36% of the patients with values 
outside of this range survived more than 3.31 years. 
Forty-two per cent of the values within the normal range 
lived longer than the mean survival period. 
Sixteen patients had platelet counts outside the 
normal range of 150,000-600,000 per cu. mm. Twelve 
per cent of these survived longer than 3.31 years. Only 
44% of the patients who had normal platelet counts sur-
vived longer than this period. 
The cellularity of the bone marrow was studied in 
this series of patients. Of the seven patients with 
normal cellularity 52% survived longer than the mean 
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period. Ninety per cent of the patients vii th markedly 
hypercellular marrows failed to survive 3.31 years. 
Five out of six patients with a decreased nu~ber 
of plasma cells in their marrow died before 3.31 years. 
Also, three out of four patients with an increase in 
marrow plasma cells failed to survive the same period 
of time. 
Seventy per cent replacement of the bone marro'vV' 
by cells of the lymphocytic series 't,,-as used as a figure 
for 90mparison. Fifty-seven per cent of patients with 
greater marrow replacement died before 3.31 years. Of 
the patients Iii th less the.n this amount of replacement 
60% diecL before the mean survi,val period was reached. 
CONCLUSION 
The following conclusions are based on this study 
of 64 patients with chronic lymphocytic leukemia at or 
near the time of diagnosis. 
1. The mean age at the time of diagnosis is substantially 
higher than that reported by other investigators. 
Thi.s may be due to the source of information. The 
average age of the pa.tient treated at the University 
of Nebraska. College of Medicine is probably higher 
than the age of patients in other serj_es. 
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2. The mean duration of survival compares favorably 
with values given by other authors. 
3. Within broad limits, a higher hemoglobin indicates 
a better prognosis. 
4. The white blood cell count shows fair correlation 
in being inversely proportional to the length of 
survival. 
5. Reticulocyte, counts outside the normal range have 
a poor prognosis. 
6. Platelet counts outside the normal range indicate 
a poor prognosis. 
7. A markedly hypercellular bone marrOy,1 indicates a 
poor prognosis. 
8. An increased or decreased nu~ber of plasma cells 
in the bone marrow carries a poor prognosis. 
9. The percentage of cells in the lymphocytic series 
gives no good indication of the eventual prognosis. 
All of the conclusions in this series are based 
upon the assumption that all of the patients are deceased. 
This was necessary in order to obtain a series large 
enough to be of some significance. Therefore, after 
all of the patients are actually deceased the conclusions 
may be markedly altered. 
-23-
BIBLIOGRAPHY 
1. Feinleib, Manning and MacMahon, Brian, Variation 
in the Duration of Survival of Patients with the 
Chronic Leukemias, Blood 15:332-349 (Mar.) 1960. 
2. Bayhoe, F.G.J., Leukaemia Research and Clinical 
Practice, Boston, Little, Brown & Co~, 1960, p. 
3. Klein, Herman and Block, Matthew, Bone Marrow 
Plasmocytosis--A Review of Sixty Cases, Blood 8: 
1034-1041 (Nov.) 1953. 
4. Lawrence, J.B. and others, Chronic Lymphatic Leukemia, 
J.A.M.A. 140:588 (June 18) 1949. 
5. Leitner, S.J., Bone l111arrow Biopsy, 'New York, Grune & 
Stratton, 1949, p. 
6. Harlow, A.A. and Bartlett, G. R. , Survival for 
Twenty-Nine Years in Chronic Lymphocytic Leukemia, 
J.A.M.A. 152:1033-1035 (July 11) 1953. 
7. Miller, S.E., A Textbook of Clinical Pathology, 
Baltimore, Williams & Wilkins Co., 1960 p. 53. 
8. Osgooa, E.E. and Seaman, A.J., Treatment of Chronic 
Leukemias, J.A.IvI.A. 150:1372-1379 (Dec.6) 1952. 
9. Shimkin, M.B. and others, Lymphocytic Leukemia: 
An Analysis of Frequency, Distribution and 
Mortality at the University of California Hospital, 
1913-1947, Ann. of Int. 14ed. 39: 1254-1265 (Dec.) 1953. 
10. U.S. Department of Commerce, Bureau of the Census~ 
Stat:i.stical Abstract of the United States, 1963, 
p.60. 
11. Ti vey ,Harold, The Prognosis for Survival in Chronic 
Granulocytic and Lymphocytic Leukemia, Am. J. of 
Roent. 72:68-93 (July) 1954. 
12. \'fasi, Prawase and Block, 1·1atthew, The Mechanism of 
the Development of Anemia in Untreated Chronic 
Lymphatic Leukemia, Blood 17:597-609 (May) 1961. 
13. Wintrobe, M.M., Clinical Hematology, Philadelphia, 
Lea & Febiger, 1961, p. 65. 
